Hepatitis Associated

Hepatitis C is a chronic viral disease that causes inflammation of the liver. Hepatitis C is one of the most common types of hepatitis, and its diagnosis and treatment have become more accessible due to the development of treatments such as interferon and ribavirin.

Hepatitis C occurs throughout the world, but is especially common in developing countries such as India, China and Southeast Asia. The hepatitis C virus is transmitted through the blood of an infected person or from mother to child during pregnancy or childbirth. Other methods of transmission include sharing a syringe for injecting drugs or sharing piercing needles.

Symptoms of hepatitis C may be mild and may not appear for several months. If symptoms begin to appear, they usually include fatigue, loss of appetite, abdominal pain, jaundice and headaches. For many patients, symptoms improve after starting treatment.

Diagnosis of hepatitis C is usually based on the determination of viral antigens in the blood. In case of a positive result, it is necessary to determine the genotype of the virus, which will help determine the need to use a specific type of drug. Treatment consists of a combination of interferon and ribavin, with the combination of drugs varying depending on the genotype of the virus. The most common side effects of treatment are fatigue, nausea, headache and depression.

An important aspect of treatment is continuous monitoring and maintaining a low viral load during treatment. This may help reduce the risk of the virus reactivating in the future and avoid possible complications. After finishing